Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
Apply
Dinutuximab, Temozolomide, Irinotecan, GM-CSF
NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step